Companies / Better Therapeutics, Inc.
Better Therapeutics, Inc.
BTTXMCADUCIK 1832415
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Apr 10, 2023 | Perry David P Executive | Buy Open-market buy | Common Stock | $3.00M | +3.6M | 3,636,364 | high |
| Oct 28, 2021 | Perry David P Executive | Buy Open-market buy | Common Stock | $2.00M | +200K +1.90% | 10,730,037 | high |
| Apr 7, 2021 | Liu Suying CEO | Sell Open-market sale | Common Stock | $1.80M | -200K -12.71% | 1,374,000 | medium |
| Apr 7, 2021 | Mountain Crest Capital LLC 10% owner | Sell Open-market sale | Common Stock | $1.80M | -200K -12.71% | 1,374,000 | medium |
| Apr 7, 2021 | Liu Dong Executive | Sell Open-market sale | Common Stock | $1.80M | -200K -12.71% | 1,374,000 | medium |
| Jan 12, 2021 | Mountain Crest Capital LLC 10% owner | Buy Open-market buy | Common Stock | $1.35M | +135K +9.43% | 1,566,500 | high |
| Jan 12, 2021 | Liu Suying CEO | Buy Open-market buy | Common Stock | $1.35M | +135K +9.43% | 1,566,500 | high |
| Jan 12, 2021 | Liu Dong Executive | Buy Open-market buy | Common Stock | $1.35M | +135K +9.43% | 1,566,500 | high |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| BTTX | common | 08773T104 |